Search

Search Constraints

You searched for: Author/Creator Subramanian, G. Mani

Search Results

1. A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH. Issue 1 (24th June 2021)

2. All‐oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment‐naïve patients with genotype 1 HCV infection. Issue 1 (28th May 2014)

3. Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH. Issue 2 (15th February 2021)

4. Development and validation of a primary sclerosing cholangitis–specific patient‐reported outcomes instrument: The PSC PRO. Issue 1 (10th May 2018)

5. Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B. Issue 1 (10th October 2019)

6. Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis. Issue 1 (9th May 2015)

7. Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis. Issue 1 (9th May 2015)

8. Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease. (5th April 2017)

9. Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials. Issue 5 (19th August 2019)

10. Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis. (May 2020)